Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Appl Biomater Funct Mater ; 22: 22808000241236590, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38444166

RESUMEN

OBJECTIVE: To evaluate the antitumor and antimicrobial properties of an alginate-based membrane (ABM) loaded with bismuth lipophilic nanoparticles (BisBAL NPs) and cetylpyridinium chloride (CPC) on clinically isolated bacteria and a pancreatic cancer cell line. MATERIAL AND METHODS: The BisBAL NP-CPC ABM was characterized using optical and scanning electron microscopy (SEM). The antimicrobial potential was measured using the disk-diffusion assay, and antibiofilm activity was determined through the live/dead assay and fluorescence microscopy. The antitumor activity was analyzed on the pancreatic cell line (Panc 03.27) using the MTT assay and live/dead assay with fluorescence microscopy. RESULTS: After a 24-h exposure (37°C, aerobic conditions), 5 µM BisBAL NP reduced the growth of K. pneumoniae by 77.9%, while 2.5 µM BisBAL NP inhibited the growth of Salmonella, E. faecalis and E. faecium by 82.9%, 82.6%, and 78%, respectively (p < 0.0001). The BisBAL NPs-CPC ABM (at a ratio of 10:1; 500 and 50 µM, respectively) inhibited the growth of all isolated bacteria, producing inhibition halos of 9.5, 11.2, 7, and 10.3 mm for K. pneumoniae, Salmonella, E. faecalis, and E. faecium, respectively, in contrast to the 6.5, 9.5, 8.5, and 9.8 mm obtained with 100 µM ceftriaxone (p < 0.0001). The BisBAL NPs-CPC ABM also reduced bacterial biofilms, with 81.4%, 74.5%, 97.1%, and 79.5% inhibition for K. pneumoniae, E. faecium, E. faecalis, and Salmonella, respectively. Furthermore, the BisBAL NPs-CPC ABM decreased Panc 03.27 cell growth by 76%, compared to 18% for drug-free ABM. GEM-ABM reduced tumoral growth by 73%. The live/dead assay confirmed that BisBAL NPs-CPC-ABM and GEM-ABM were cytotoxic for the turmoral Panc 03.27 cells. CONCLUSION: An alginate-based membrane loaded with BisBAL NP and CPC exhibits dual antimicrobial and antitumoral efficacy. Therefore, it could be applied in cancer treatment and to diminish the occurrence of surgical site infections.


Asunto(s)
Antiinfecciosos , Bismuto , Dimercaprol/análogos & derivados , Compuestos Organometálicos , Cetilpiridinio/farmacología , Antiinfecciosos/farmacología , Alginatos/farmacología , Klebsiella pneumoniae
2.
J Appl Biomater Funct Mater ; 21: 22808000231161177, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36942951

RESUMEN

OBJECTIVE: To determine the combined antitumor effect of bismuth lipophilic nanoparticles (BisBAL NP) and cetylpyridinium chloride (CPC) on human lung tumor cells. MATERIAL AND METHODS: The human lung tumor cells A549 were exposed to 1-100 µM BisBAL NP or CPC, either separately or in a 1:1 combination. Cell viability was measured with the PrestoBlue assay, the LIVE/DEAD assay, and fluorescence microscopy. The integrity and morphology of cellular microtubules were analyzed by immunofluorescence. RESULTS: A 24-h exposure to 1 µM solutions reduced A549 growth with 21.5% for BisBAL NP, 70.5% for CPC, and 92.4% for the combination (p < 0.0001), while a 50 µM BisBAL NP/CPC mixture inhibited cell growth with 99% (p < 0.0001). BisBAL NP-curcumin conjugates were internalized within 30 min of exposure and could be traced within the nucleus of tumor cells within 2 h. BisBAL NP, but not CPC, interfered with microtubule organization, thus interrupting cell replication, similar to the action mechanism of docetaxel. CONCLUSION: The growth inhibition of A549 human tumor cells by BisBAL NP and CPC was cumulative as of 1 µM. The BisBAL NP/CPC combination may constitute an innovative and cost-effective alternative for treating human lung cancer.


Asunto(s)
Neoplasias Pulmonares , Nanopartículas , Humanos , Bismuto , Cetilpiridinio/farmacología , Neoplasias Pulmonares/tratamiento farmacológico
3.
J Appl Biomater Funct Mater ; 20: 22808000221092157, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35485910

RESUMEN

OBJECTIVE: Analyze the antitumor capacity of cetylpyridinium chloride (CPC) on human breast tumor cells, and the possible action mechanism. MATERIAL AND METHODS: The human breast tumor cells MCF-7 and no-tumor breast cells MCF-10A were exposed to CPC under various condition (concentration and duration). Cell viability was measured with MTT assay, the LIVE/DEAD assay, and fluorescence microscopy. Membrane permeability after CPC exposure was evaluated by Calcein AM assay, mitochondrial morphology with a MitoView staining, and genotoxicity with the comet assay and fluorescence microscopy. RESULTS: CPC was cytotoxic to both MCF-7 and MCF-10A as of a 24-h exposure to 0.1 µM. Cytotoxicity was dose-dependent and reached 91% for MCF-7 and 78% for MCF-10A after a 24-h exposure to 100 µM CPC, which outperformed the positive control doxorubicin in effectiveness and selectivity. The LD50 of CPC on was 6 µM for MCF-7 and 8 µM for MCF-10A, yielding a selectivity index of 1.41. A time response analysis revealed 64% dead cells after only 5 min of exposure to 100 µM CPC. With respect to the action mechanisms, the comet assay did not reveal genome fragmentation. On the other hand, membrane damage was dose-dependent and may also affect mitochondrial morphology. CONCLUSION: Cetylpyridinium chloride inhibits MCF-7 cell growing in a non-selective way as of 5 min of exposure. The action mechanism of CPC on tumor cells involves cell membrane damage without change neither mitochondrial morphology nor genotoxicity.


Asunto(s)
Antineoplásicos , Neoplasias de la Mama , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/patología , Supervivencia Celular , Cetilpiridinio/farmacología , Femenino , Humanos , Células MCF-7
4.
Anticancer Agents Med Chem ; 22(14): 2548-2557, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35168526

RESUMEN

AIM: The objective of this study was to analyze the antitumor effect of BisBAL NP in a mouse melanoma model. MATERIALS AND METHODS: The antitumor activity of BisBAL NP on murine B16-F10 melanoma cells was determined both in vitro (PrestoBlue cell viability assay and Live/Dead fluorescence) and in vivo, in a mouse model, with the following 15-day treatments: BisBAL NP, negative control (PBS), and cell-death control (docetaxel; DTX). Mouse survival and weight, as well as the tumor volume, were recorded daily during the in vivo study. RESULTS: BisBAL NP were homogeneous in size (mean diameter, 14.7 nm) and bismuth content. In vitro, 0.1 mg/mL BisBAL NP inhibited B16-F10 cell growth stronger (88%) than 0.1 mg/mL DTX (82%) (*p<0.0001). In vivo, tumors in mice treated with BisBAL NP (50 mg/kg/day) or DTX (10 mg/kg/day) were 76% and 85% smaller than the tumors of negative control mice (*p<0.0001). The average weight of mice was 18.1 g and no statistically significant difference was detected among groups during the study. Alopecia was only observed in all DTX-treated mice. The survival rate was 100% for the control and BisBAL NP groups, but one DTX- treated mouse died at the end of the treatment period. The histopathological analysis revealed that exposure to BisBAL NP was cytotoxic for tumor tissue only, without affecting the liver or kidney. CONCLUSION: BisBAL NP decreased the tumor growing in a mouse melanoma model without secondary effects, constituting an innovative low-cost alternative to treat melanoma.


Asunto(s)
Antineoplásicos , Melanoma Experimental , Nanopartículas , Animales , Antineoplásicos/farmacología , Bismuto/farmacología , Línea Celular Tumoral , Dimercaprol/análogos & derivados , Dimercaprol/farmacología , Humanos , Melanoma Experimental/tratamiento farmacológico , Ratones , Compuestos Organometálicos
5.
Biomed Res Int ; 2021: 6960143, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34796235

RESUMEN

OBJECTIVE: To evaluate the effect of the combination of calcium hydroxide (Ca(OH)2) and a novel electrolyzed superoxidized solution at neutral pH, known as OxOral® on Enterococcus faecalis growth in root canals. METHODS: Sixty human teeth were used, from which root canals were infected and randomly divided into the following treatment groups: saline solution, saline solution plus Ca(OH)2, OxOral®, and OxOral® plus Ca(OH)2. RESULTS: A permanent reduction in bacterial growth was observed at days 1, 6, 12, and 18 after OxOral® plus Ca(OH)2 treatment from 4.4 ± 0.074 log10 CFU/mL to 0.0 ± 0.001 log10 CFU/mL. In addition, alkaline conditions maintenance was observed from application time (pH = 12.2 ± 0.033) to 18 d posttreatment (pH = 12.6 ± 0.083). CONCLUSION: The combination of OxOral® and Ca(OH)2 provides an alkaline pH and inhibits E. faecalis growth into the root canals. Our study opens the possibility for further research on the use of OxOral® in endodontic therapy.


Asunto(s)
Antiinfecciosos/administración & dosificación , Hidróxido de Calcio/administración & dosificación , Cavidad Pulpar/efectos de los fármacos , Cavidad Pulpar/microbiología , Enterococcus faecalis/efectos de los fármacos , Peróxido de Hidrógeno/administración & dosificación , Enterococcus faecalis/crecimiento & desarrollo , Humanos , Peróxido de Hidrógeno/química , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Irrigantes del Conducto Radicular/administración & dosificación , Irrigantes del Conducto Radicular/química , Tratamiento del Conducto Radicular/métodos , Soluciones
6.
Rev. ADM ; 76(5): 278-281, sept.-oct. 2019.
Artículo en Español | LILACS | ID: biblio-1053117

RESUMEN

La instrumentación mecánica durante el tratamiento periodontal trae consigo la formación de escombros microcristalinos que inhiben la adhesión tisular a la superfi cie radicular y favorece la proliferación bacteriana, lo cual perjudica los resultados del tratamiento periodontal a corto y largo plazo. Hoy en día el acondicionamiento radicular con el uso de biomodifi cadores es una opción de tratamiento adicional en el tratamiento de la periodontitis y el tratamiento de cobertura radicular. El objetivo del presente estudio es realizar una revisión de la literatura acerca de las aplicaciones y del acondicionamiento radicular con ácido cítrico, tetraciclina, EDTA y láser en el tratamiento periodontal no quirúrgico y quirúrgico (AU)


Mechanical instrumentation during periodontal treatment brings the formation of microcrystalline debris that inhibits tissue adhesion to the root surface and favors bacterial proliferation, which harms the results of the short and long term periodontal treatment. Nowadays, root conditioning with the use of biomodifi cators is an additional treatment option in the treatment of periodontitis and root coverage therapy. The aim of the present study is to conduct a literature review about the applications and the root conditioning with citric acid, tetracycline, EDTA and laser in the non surgical and surgical periodontal treatment (AU)


Asunto(s)
Humanos , Enfermedades Periodontales/cirugía , Enfermedades Periodontales/terapia , Raíz del Diente/efectos de los fármacos , Tetraciclinas , Raspado Dental , Aplanamiento de la Raíz , Ácido Edético , Ácido Cítrico , Terapia por Láser
7.
Dent Mater J ; 38(4): 611-620, 2019 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-31105160

RESUMEN

The objective of this work was to analyze the antimicrobial and antibiofilm activities of bismuth lipophilic nanoparticles (BisBAL NPs) incorporated into chitosan-based membranes. Chitosan-based membranes were homogeneously embedded with BisBAL NPs, confirming the bismuth presence by scanning electron microscopy. The tensile strength of chitosan-based membrane alone or with BisBAL NPs showed similar results as elongation, suggesting that BisBAL NP addition did not affect membrane mechanical properties. Chitosan-based membranes complemented with 100 µM of BisBAL NPs caused a complete inhibition of biofilm formation and a 90-98% growth inhibition of six different oral pathogens. Cytotoxicity studies revealed that 80% of human gingival fibroblasts were viable after a 24-h exposure to the chitosan-based membrane with 100 µM of BisBAL NPs and collagen. Altogether, we conclude that the biological properties of chitosan-based membranes supplemented with BisBAL NPs could be a very interesting option for tissue regeneration.


Asunto(s)
Antiinfecciosos , Quitosano , Nanopartículas , Antibacterianos , Bismuto , Humanos
8.
Int J Nanomedicine ; 13: 6089-6097, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30323596

RESUMEN

AIM: The objective of this study was to evaluate the antitumor activity of lipophilic bismuth nanoparticles (BisBAL NPs) on breast cancer cells. MATERIALS AND METHODS: The effect of varying concentrations of BisBAL NPs was evaluated on human MCF-7 breast cancer cells and on MCF-10A fibrocystic mammary epitheliocytes as noncancer control cells. Cell viability was evaluated with the MTT assay, plasma membrane integrity was analyzed with the calcein AM assay, genotoxicity with the comet assay, and apoptosis with the Annexin V/7-AAD assay. RESULTS: BisBAL NPs were spherical in shape (average diameter, 28 nm) and agglomerated into dense electronic clusters. BisBAL NP induced a dose-dependent growth inhibition. Most importantly, growth inhibition was higher for MCF-7 cells than for MCF-10A cells. At 1 µM BisBAL NP, MCF-7 growth inhibition was 51%, while it was 11% for MCF-10A; at 25 µM BisBAL NP, the growth inhibition was 81% for MCF-7 and 24% for MCF-10A. With respect to mechanisms of action, a 24-hour exposure of 10 and 100 µM BisBAL NP caused loss of cell membrane integrity and fragmentation of tumor cell DNA. BisBAL NPs at 10 µM were genotoxic to and caused apoptosis of breast cancer cells. CONCLUSION: BisBAL NP-induced growth inhibition is dose dependent, and breast cancer cells are more vulnerable than noncancer breast cells. The mechanism of action of BisBAL NPs may include loss of plasma membrane integrity and a genotoxic effect on the genomic DNA of breast cancer cells.


Asunto(s)
Antineoplásicos/farmacología , Bismuto/farmacología , Neoplasias de la Mama/patología , Dimercaprol/análogos & derivados , Nanopartículas/química , Compuestos Organometálicos/farmacología , Apoptosis/efectos de los fármacos , Permeabilidad de la Membrana Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ensayo Cometa , Daño del ADN , Dimercaprol/farmacología , Femenino , Humanos , Células MCF-7 , Nanopartículas/ultraestructura
9.
Odontol. vital ; jun. 2016.
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1506812

RESUMEN

Este estudio contempla el análisis y comparación del sellado intracoronal en 50 órganos dentarios unirradiculares humanos extraídos, a los que se les realizó tratamiento endodóntico; posteriormente se dividieron en 5 grupos, de 10 cada uno, aplicando en 4 de los grupos los materiales utilizados como método barrera: Cavit G, Ketac Molar, Perma Seal, Single Bond y 1 grupo aparte de control que fue conformado sin ningún tipo de material de barrera. Luego fueron sumergidos en saliva artificial durante 1 mes; transcurrido este tiempo fueron teñidos con azul de metileno al 2% y se procedió a realizar los cortes para su estudio, evaluando la filtración corono apical en 7 secciones de 1mm cada una en toda la longitud radicular, inmediatamente después del material utilizado como método de barrera. Resultados: Se encontró que el adhesivo Single Bond fue el más eficaz como material barrera y que evitó la filtración corono apical.


This study analizes and compares the intracoronal sealing of 50 extracted, single rooted, human dental organs that underwent endodontic treatment; they were divided in 5 groups of 10 each, applying the materials used as barrier method: Cavit G, Ketac Molar, Perma Seal, Single Bond and to 4 groups and leaving one control group without any barrier material. Afterwards they were submerged in artificial saliva for 1 month; after this time they were stained with methylene blue at 2% and proceeded to make the cuts for their study, evaluating crown-apical filtration in 7 sections of 1 mm each along the entire root length starting immediately after the material used as a barrier method. Results: found that the adhesive Single Bond was the most effective as material barrier to avoid crown-apical filtration

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...